secwatch / observer
8-K filed January 25, 2023, 6:59 PM ET ticker IART CIK 0000917520
leadership confidence high sentiment neutral materiality 0.50

Integra LifeSciences CFO Carrie Anderson resigns effective Feb 2, 2023; interim finance leaders appointed

INTEGRA LIFESCIENCES HOLDINGS CORP

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Carrie Anderson

Chief Financial Officer
IART · INTEGRA LIFESCIENCES HOLDINGS CORP
Effective
2023-02-02
Filed
January 25, 2023, 6:59 PM ET
On January 25, 2023, Carrie Anderson, Chief Financial Officer of Integra LifeSciences Holdings Corporation (the “Company”), notified the Company of her decision to resign, effective as of February 2, 2023, to pursue another professional opportunity.
Appointed (interim)

Mathieu P. Aussermeier

Vice President, Corporate Finance, Investor Relations & Treasurer
IART · INTEGRA LIFESCIENCES HOLDINGS CORP
Effective
2023-02-02
Filed
January 25, 2023, 6:59 PM ET
In the interim, Mathieu P. Aussermeier, Vice President, Corporate Finance, Investor Relations & Treasurer, and Jeffrey Mosebrook, Senior Vice President, Finance, will assume Ms. Anderson’s financial duties and responsibilities and report to Jan De Witte, the Company’s President and Chief Executive Officer.
Appointed (interim)

Jeffrey Mosebrook

Senior Vice President, Finance
IART · INTEGRA LIFESCIENCES HOLDINGS CORP
Effective
2023-02-02
Filed
January 25, 2023, 6:59 PM ET
In the interim, Mathieu P. Aussermeier, Vice President, Corporate Finance, Investor Relations & Treasurer, and Jeffrey Mosebrook, Senior Vice President, Finance, will assume Ms. Anderson’s financial duties and responsibilities and report to Jan De Witte, the Company’s President and Chief Executive Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Carrie Anderson resigned as Chief Financial Officer at INTEGRA LIFESCIENCES HOLDINGS CORP.

Action
resigned
Role
Chief Financial Officer
Exact text from the filing
On January 25, 2023, Carrie Anderson, Chief Financial Officer of Integra LifeSciences Holdings Corporation (the “Company”), notified the Company of her decision to resign, effective as of February 2, 2023, to pursue another professional opportunity.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.9

Mathieu P. Aussermeier was appointed as Vice President, Corporate Finance, Investor Relations & Treasurer at INTEGRA LIFESCIENCES HOLDINGS CORP.

Action
assumes duties
Role
Vice President, Corporate Finance, Investor Relations & Treasurer
Exact text from the filing
In the interim, Mathieu P. Aussermeier, Vice President, Corporate Finance, Investor Relations & Treasurer, and Jeffrey Mosebrook, Senior Vice President, Finance, will assume Ms. Anderson’s financial duties and responsibilities and report to Jan De Witte, the Company’s President and Chief Executive Officer.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.9

Jeffrey Mosebrook was appointed as Senior Vice President, Finance at INTEGRA LIFESCIENCES HOLDINGS CORP.

Action
assumes duties
Role
Senior Vice President, Finance
Exact text from the filing
In the interim, Mathieu P. Aussermeier, Vice President, Corporate Finance, Investor Relations & Treasurer, and Jeffrey Mosebrook, Senior Vice President, Finance, will assume Ms. Anderson’s financial duties and responsibilities and report to Jan De Witte, the Company’s President and Chief Executive Officer.
View on SEC.gov

INTEGRA LIFESCIENCES HOLDINGS CORP filing history →

Source: SEC EDGAR
accession 0000917520-23-000007
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.